Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of UK-390,957 in Premature Ejaculation Extension
NCT00219609Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2005
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of UK-390957 in premature ejaculation (PE), sponsored by Pfizer. Started Jan 2005; status: completed.
02
Drugs
UK-390957
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT00219609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219609.